US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IntelliPharmaCeutics

0.2106

0.0000

Volume:- -

Turnover:- -

Market Cap:9.17M

PE:-0.60

High:0.2106

Open:0.2106

Low:0.2106

Close:0.2106

Loading ...

Overview Company News Filings

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

Intellipharmaceutics国际公司。

Report of foreign issuer

宣布发行的美国和加拿大的专利覆盖方面PODRAS™过量技术

Report of foreign issuer

出席了LD微主要事件

Report of foreign issuer

提交新药申请Rexista®(盐酸羟考酮延长释放),滥用威慑阿片类镇痛药治疗中度到重度的疼痛

Report of foreign issuer

2016年第三季度管理讨论和分析

Report of foreign issuer

出席道森詹姆斯证券增长股会议

Report of foreign issuer

FDA宣布初步批准通用奎硫平缓释片®

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IPCI/filings?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPCI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPCI\",,,,,undefined,":{"symbol":"IPCI","market":"US","secType":"STK","nameCN":"IntelliPharmaCeutics","latestPrice":0.2106,"timestamp":1567195200000,"preClose":0.2106,"halted":0,"volume":0,"delay":0,"floatShares":18000000,"shares":43537850,"eps":-0.35,"marketStatus":"Trading","change":0,"latestTime":"05-22 15:56:00 EDT","open":0.2106,"high":0.2106,"low":0.2106,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.35,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747944000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.2106,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPCI\",,,,,undefined,":{"symbol":"IPCI","floatShares":18000000,"roa":"--","roe":"--","lyrEps":0,"shares":43537850,"dividePrice":0,"high":0.2106,"amplitude":0,"preClose":0.2106,"low":0.2106,"week52Low":0.2001,"pbRate":"-11.57","week52High":6.6,"institutionHeld":0,"latestPrice":0.2106,"eps":-0.35,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.35,"open":0.2106,"prevYearClose":0.2106},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"IPCI\",pageSize:20,pageCount:5,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"1864380","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417007059-IPCI","pdf_url":null,"pub_time":1502175920000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417007059/0001654954-17-007059-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417007059/form6-k.htm","primary":true,"translateUrl":null,"linkName":"form6-k.htm","type":"6-K","id":"NTFILEDdJd8xqHSJituVWw","market":"us","size":18056},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417007059/ex991.htm","primary":false,"translateUrl":null,"linkName":"ex991.htm","type":"EX-99.1","id":"NTFILEBKDAXXHbt8kbhngX","market":"us","size":22633},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417007059/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILEFA1UxfBPauUhNcDc","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-08-08 15:05","pubTimestamp":1502175920,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1850165","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417006750-IPCI","pdf_url":null,"pub_time":1501459746000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417006750/0001654954-17-006750-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006750/form6-k.htm","primary":true,"translateUrl":null,"linkName":"form6-k.htm","type":"6-K","id":"NTFILEAUc8UmvuCH2vdCtQ","market":"us","size":18131},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006750/ex991.htm","primary":false,"translateUrl":null,"linkName":"ex991.htm","type":"EX-99.1","id":"NTFILECEYj26Lsj8a1ScYi","market":"us","size":22929},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006750/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE3NuBu7tFjPbRkNnS","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-07-31 08:09","pubTimestamp":1501459746,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"1828750","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417006310-IPCI","pdf_url":null,"pub_time":1499765115000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417006310/0001654954-17-006310-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-07-11 17:25","pubTimestamp":1499765115,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1816114","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417006048-IPCI","pdf_url":null,"pub_time":1498810274000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417006048/0001654954-17-006048-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006048/form6-k.htm","primary":true,"translateUrl":null,"linkName":"form6-k.htm","type":"6-K","id":"NTFILEC1JgrQuETNwxsF1o","market":"us","size":17368},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006048/ex991.htm","primary":false,"translateUrl":null,"linkName":"ex991.htm","type":"EX-99.1","id":"NTFILEEDGUruGWg1S4tLHx","market":"us","size":27802},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417006048/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILEEVJFi6PAQtPPhg6h","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-06-30 16:11","pubTimestamp":1498810274,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1760782","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417005368-IPCI","pdf_url":null,"pub_time":1496710469000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417005368/0001654954-17-005368-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005368/form6-k.htm","primary":true,"translateUrl":null,"linkName":"form6-k.htm","type":"6-K","id":"NTFILEFHzg1dQWT94dJGgp","market":"us","size":17973},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005368/ex991.htm","primary":false,"translateUrl":null,"linkName":"ex991.htm","type":"EX-99.1","id":"NTFILEDhKCcZAw11S79DQz","market":"us","size":22587},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005368/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE5ieqfGHurRyen5dk","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-06-06 08:54","pubTimestamp":1496710469,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1730576","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417005062-IPCI","pdf_url":null,"pub_time":1495613696000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417005062/0001654954-17-005062-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005062/form6-kfilingmay242017.htm","primary":true,"translateUrl":null,"linkName":"form6-kfilingmay242017.htm","type":"6-K","id":"NTFILE2Y2MY1KxbfvHmttB","market":"us","size":17702},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005062/exh991.htm","primary":false,"translateUrl":null,"linkName":"exh991.htm","type":"EX-99.1","id":"NTFILE3VhiKxMCd6ZxEZhw","market":"us","size":22683},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417005062/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE6upJvp5f6dFT8H1X","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-05-24 16:14","pubTimestamp":1495613696,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1690200","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417004326-IPCI","pdf_url":null,"pub_time":1494400840000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417004326/0001654954-17-004326-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417004326/form6-k_may102017.htm","primary":true,"translateUrl":null,"linkName":"form6-k_may102017.htm","type":"6-K","id":"NTFILE5KUXqZY3ex3dri1W","market":"us","size":17546},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417004326/ex991.htm","primary":false,"translateUrl":null,"linkName":"ex991.htm","type":"EX-99.1","id":"NTFILEGSz49QaQZrQ9QXVD","market":"us","size":23956},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417004326/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILEJ652z4udWPBkV2yc","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-05-10 15:20","pubTimestamp":1494400840,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"1571914","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417003170-IPCI","pdf_url":null,"pub_time":1491782618000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417003170/0001654954-17-003170-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-04-10 08:03","pubTimestamp":1491782618,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"1498670","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417002058-IPCI","pdf_url":null,"pub_time":1489622918000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417002058/0001654954-17-002058-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-03-16 08:08","pubTimestamp":1489622918,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1441889","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417001405-IPCI","pdf_url":null,"pub_time":1487894690000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417001405/0001654954-17-001405-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417001405/form6-kfilingfebruary2420.htm","primary":true,"translateUrl":null,"linkName":"form6-kfilingfebruary2420.htm","type":"6-K","id":"NTFILE3VXqPRF2JkKZmxY9","market":"us","size":17870},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417001405/pressrelease_intellipharm.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_intellipharm.htm","type":"EX-99.1","id":"NTFILEFdE2EDrjZRQV8DhJ","market":"us","size":21840},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417001405/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE146rTeuzCrffHbVS","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-02-24 08:04","pubTimestamp":1487894690,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1403702","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417000913-IPCI","pdf_url":null,"pub_time":1486685210000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/0001654954-17-000913-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/form_6-k.htm","primary":true,"translateUrl":null,"linkName":"form_6-k.htm","type":"6-K","id":"NTFILE4ayiEnVEMArEqnVy","market":"us","size":21380},{"description":"CONSENTS OF EXPERTS AND COUNSEL","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/ex_23-1.htm","primary":false,"translateUrl":null,"linkName":"ex_23-1.htm","type":"EX-23.1","id":"NTFILEXipDJWapKhs6HAhq","market":"us","size":5508},{"description":"CONSENTS OF EXPERTS AND COUNSEL","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/ex_23-2.htm","primary":false,"translateUrl":null,"linkName":"ex_23-2.htm","type":"EX-23.2","id":"NTFILE7mDcGXfFYXxRd95u","market":"us","size":7077},{"description":"ADDITIONAL EXHIBITS","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/ex_99-1.htm","primary":false,"translateUrl":null,"linkName":"ex_99-1.htm","type":"EX-99.1","id":"NTFILEUVWsPc34DMioiVDZ","market":"us","size":748235},{"description":"ADDITIONAL EXHIBITS","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/ex_99-2.htm","primary":false,"translateUrl":null,"linkName":"ex_99-2.htm","type":"EX-99.2","id":"NTFILE3hDBrawpzsk3MUf6","market":"us","size":1448911},{"description":"ADDITIONAL EXHIBITS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/ex_99-3.htm","primary":false,"translateUrl":null,"linkName":"ex_99-3.htm","type":"EX-99.3","id":"NTFILE2c9Z9ggbr75j5tDe","market":"us","size":314551},{"description":"IMAGE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/deloitte_logo.jpg","primary":false,"translateUrl":null,"linkName":"deloitte_logo.jpg","type":"GRAPHIC","id":"NTFILEHjCpnNvzfFZonHdn","market":"us","size":2439},{"description":"IMAGE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILEFAT49YRFoNqXmZUQ","market":"us","size":4539},{"description":"IMAGE","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/mnp_address-1.jpg","primary":false,"translateUrl":null,"linkName":"mnp_address-1.jpg","type":"GRAPHIC","id":"NTFILE7vADigd6isrktc3R","market":"us","size":5048},{"description":"IMAGE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/mnp_address-2.jpg","primary":false,"translateUrl":null,"linkName":"mnp_address-2.jpg","type":"GRAPHIC","id":"NTFILEEasBjZLx59LXCSht","market":"us","size":6286},{"description":"IMAGE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000913/mnp_logo.jpg","primary":false,"translateUrl":null,"linkName":"mnp_logo.jpg","type":"GRAPHIC","id":"NTFILECz8BkTRbB8Sr8875","market":"us","size":2454}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-02-10 08:06","pubTimestamp":1486685210,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1385268","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417000719","pdf_url":null,"pub_time":1486026231000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417000719/0001654954-17-000719-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000719/ipci_form6-k.htm","primary":true,"translateUrl":null,"linkName":"ipci_form6-k.htm","type":"6-K","id":"NTFILE7uAGMj2VLXt6EGpX","market":"us","size":16981},{"description":"EXHIBITS 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000719/pressrelease_intellipharm.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_intellipharm.htm","type":"EX-99.1","id":"NTFILEDCT4LPf6G5Ty5Pr2","market":"us","size":27730},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000719/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE51sgdRvfWcTVeV5Y","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-02-02 17:03","pubTimestamp":1486026231,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1337054","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495417000086","pdf_url":null,"pub_time":1483661764000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495417000086/0001654954-17-000086-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000086/ipci_form6-k.htm","primary":true,"translateUrl":null,"linkName":"ipci_form6-k.htm","type":"6-K","id":"NTFILEDgzL15GPQmhNjAFD","market":"us","size":17615},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000086/pressrelease_intellipharm.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_intellipharm.htm","type":"EX-99.1","id":"NTFILEGi9yRMsj3kYsw9qr","market":"us","size":23335},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495417000086/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE9LiEY5yJCvUzusTP","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2017-01-06 08:16","pubTimestamp":1483661764,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1317286","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416005146","pdf_url":null,"pub_time":1482969754000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Intellipharmaceutics国际公司。","symbol":"IPCI","title":"Intellipharmaceutics国际公司。","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416005146/0001654954-16-005146-index.htm","us_notice_code":"Form 6-K","us_title_en":"Intellipharmaceutics International Inc.  ","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005146/form6-k.htm","primary":true,"translateUrl":null,"linkName":"form6-k.htm","type":"6-K","id":"NTFILE6edhjAfeMnTCXJ8V","market":"us","size":17883},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005146/pressrelease_intellipharm.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_intellipharm.htm","type":"EX-99.1","id":"NTFILEFcg1yZJQbEEM42Dx","market":"us","size":20320},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005146/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE138EqRPdtwHizddC","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-12-29 08:02","pubTimestamp":1482969754,"title_zh":"Intellipharmaceutics国际公司。","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1302430","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416005045","pdf_url":null,"pub_time":1482249600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"宣布发行的美国和加拿大的专利覆盖方面PODRAS™过量技术","symbol":"IPCI","title":"宣布发行的美国和加拿大的专利覆盖方面PODRAS™过量技术","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416005045/0001654954-16-005045-index.htm","us_notice_code":"Form 6-K","us_title_en":"Announces Issuance of U.S. and Canadian Patents Covering Aspects of Its PODRAS™ Overdose Technology","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005045/ipci_form6-k.htm","primary":true,"translateUrl":null,"linkName":"ipci_form6-k.htm","type":"6-K","id":"NTFILE7Qt33uurBJWaPL8y","market":"us","size":18028},{"description":"EXHIBIT .1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005045/pressrelease_intellipharm.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_intellipharm.htm","type":"EX-99.1","id":"NTFILEHEmE7Y2a1K4zsyJ7","market":"us","size":24773},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416005045/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILEEL8zDPDsMgAr6Tbr","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-12-21 00:00","pubTimestamp":1482249600,"title_zh":"宣布发行的美国和加拿大的专利覆盖方面PODRAS™过量技术","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1258051","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416004374","pdf_url":null,"pub_time":1480348800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"出席了LD微主要事件","symbol":"IPCI","title":"出席了LD微主要事件","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416004374/0001654954-16-004374-index.htm","us_notice_code":"Form 6-K","us_title_en":"To Present at the LD Micro Main Event","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416004374/form6-k_20161128.htm","primary":true,"translateUrl":null,"linkName":"form6-k_20161128.htm","type":"6-K","id":"NTFILE59mioJvWaQE7dBsx","market":"us","size":17203},{"description":"EXHIBIT 99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416004374/pressrelease_ldmicromaine.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_ldmicromaine.htm","type":"EX-99.1","id":"NTFILEABbVxeXUE2ZP9YY4","market":"us","size":18719},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416004374/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE3AeucJjNAa56gvRb","market":"us","size":7239}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-11-29 00:00","pubTimestamp":1480348800,"title_zh":"出席了LD微主要事件","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"1256093","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416004315","pdf_url":null,"pub_time":1480003200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"提交新药申请Rexista®(盐酸羟考酮延长释放),滥用威慑阿片类镇痛药治疗中度到重度的疼痛","symbol":"IPCI","title":"提交新药申请Rexista®(盐酸羟考酮延长释放),滥用威慑阿片类镇痛药治疗中度到重度的疼痛","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416004315/0001654954-16-004315-index.htm","us_notice_code":"Form 6-K","us_title_en":"Submits New Drug Application for Rexista® (Oxycodone Hydrochloride Extended Release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-11-25 00:00","pubTimestamp":1480003200,"title_zh":"提交新药申请Rexista®(盐酸羟考酮延长释放),滥用威慑阿片类镇痛药治疗中度到重度的疼痛","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1031561","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416002818","pdf_url":null,"pub_time":1476374400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"2016年第三季度管理讨论和分析","symbol":"IPCI","title":"2016年第三季度管理讨论和分析","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/0001654954-16-002818-index.htm","us_notice_code":"Form 6-K","us_title_en":"2016 Third Quarter Management Discussion and Analysis","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_form6-k.htm","primary":true,"translateUrl":null,"linkName":"ipc_form6-k.htm","type":"6-K","id":"NTFILEHKR6D8z5nfnSrXt6","market":"us","size":24631},{"description":"ADDITIONAL EXHIBITS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_exhibit99-1.htm","primary":false,"translateUrl":null,"linkName":"ipc_exhibit99-1.htm","type":"EX-99.1","id":"NTFILEF53vyTZp2BnLsCgX","market":"us","size":586708},{"description":"ADDITIONAL EXHIBITS","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_exhibit99-2.htm","primary":false,"translateUrl":null,"linkName":"ipc_exhibit99-2.htm","type":"EX-99.2","id":"NTFILE4SHRirsatbgnTECD","market":"us","size":897093},{"description":"ADDITIONAL EXHIBITS","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_exhibit99-3.htm","primary":false,"translateUrl":null,"linkName":"ipc_exhibit99-3.htm","type":"EX-99.3","id":"NTFILE34BBgHk8v2VLp3o5","market":"us","size":337515},{"description":"ADDITIONAL EXHIBITS","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_exhibit99-4.htm","primary":false,"translateUrl":null,"linkName":"ipc_exhibit99-4.htm","type":"EX-99.4","id":"NTFILECUHeNg5ES49X4K61","market":"us","size":19020},{"description":"ADDITIONAL EXHIBITS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/ipc_exhibit99-5.htm","primary":false,"translateUrl":null,"linkName":"ipc_exhibit99-5.htm","type":"EX-99.5","id":"NTFILE9WdJ5hT71GJxCvP4","market":"us","size":19377},{"description":"CORPORATE LOGO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002818/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE3t6CJTdEBnuEZC5n","market":"us","size":6274}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-10-14 00:00","pubTimestamp":1476374400,"title_zh":"2016年第三季度管理讨论和分析","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1031560","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416002823","pdf_url":null,"pub_time":1476374400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"出席道森詹姆斯证券增长股会议","symbol":"IPCI","title":"出席道森詹姆斯证券增长股会议","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416002823/0001654954-16-002823-index.htm","us_notice_code":"Form 6-K","us_title_en":"To Present at Dawson James Securities Growth Stock Conference","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002823/form6-k_20161012.htm","primary":true,"translateUrl":null,"linkName":"form6-k_20161012.htm","type":"6-K","id":"NTFILEAuFUwcheZDR8uYUE","market":"us","size":18056},{"description":"ADDITIONAL EXHIBITS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002823/pressrelease_dawsonjamess.htm","primary":false,"translateUrl":null,"linkName":"pressrelease_dawsonjamess.htm","type":"EX-99.1","id":"NTFILEEmn6pdxt94texosk","market":"us","size":19215},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002823/logo.jpg","primary":false,"translateUrl":null,"linkName":"logo.jpg","type":"GRAPHIC","id":"NTFILECBaH23KxDm97iPTH","market":"us","size":5019}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-10-14 00:00","pubTimestamp":1476374400,"title_zh":"出席道森詹姆斯证券增长股会议","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"1031563","market":"us","labels":[],"media":"sec.gov","original_id":"AN165495416002729","pdf_url":null,"pub_time":1476115200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"FDA宣布初步批准通用奎硫平缓释片®","symbol":"IPCI","title":"FDA宣布初步批准通用奎硫平缓释片®","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"http://www.sec.gov/Archives/edgar/data/1474835/000165495416002729/0001654954-16-002729-index.htm","us_notice_code":"Form 6-K","us_title_en":"Announces FDA Tentative Approval for Generic Seroquel XR®","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRIMARY DOCUMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002729/form6-kfilingocotober7201.htm","primary":true,"translateUrl":null,"linkName":"form6-kfilingocotober7201.htm","type":"6-K","id":"NTFILECKdKjtfSo7qKxAPV","market":"us","size":20227},{"description":"ADDITIONAL EXHIBITS","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002729/pr_genericseroquelfinal.htm","primary":false,"translateUrl":null,"linkName":"pr_genericseroquelfinal.htm","type":"EX-99.1","id":"NTFILEAS9otwBE5GbjFkBm","market":"us","size":18883},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1474835/000165495416002729/intellipharmaceutics_logo.jpg","primary":false,"translateUrl":null,"linkName":"intellipharmaceutics_logo.jpg","type":"GRAPHIC","id":"NTFILE2YnJeZ4PjgaHBrvr","market":"us","size":19441}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2016-10-11 00:00","pubTimestamp":1476115200,"title_zh":"FDA宣布初步批准通用奎硫平缓释片®","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":5,"totalSize":242,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPCI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-02-22","symbol":"IPCI","fiscalQuarterEnding":"2018/11","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1550811600000,"reportTimeType":"","actualEps":-0.67},{"date":"2018-09-14","symbol":"IPCI","type":"split","dateTimestamp":1536897600000,"forFactor":10,"toFactor":1},{"market":"US","date":"2018-07-16","symbol":"IPCI","fiscalQuarterEnding":"2018/05","expectedEps":-0.07,"name":null,"time":"","type":"earning","dateTimestamp":1531713600000,"reportTimeType":"","actualEps":-0.07},{"market":"US","date":"2018-02-16","symbol":"IPCI","fiscalQuarterEnding":"2017/11","expectedEps":-0.07,"name":null,"time":"","type":"earning","dateTimestamp":1518757200000,"reportTimeType":"","actualEps":-0.08},{"market":"US","date":"2017-10-10","symbol":"IPCI","fiscalQuarterEnding":"2017/08","expectedEps":-0.04,"name":null,"time":"","type":"earning","dateTimestamp":1507608000000,"reportTimeType":"","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPCI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPCI\",market:\"US\",delay:false,,,undefined,":{}}}